 | • レポートコード：C-GIR20G2754 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「血色素障害の世界市場2019年」は、グローバルにおける血色素障害市場を展望するレポートです。血色素障害のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・血色素障害の市場概観 ・血色素障害の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・血色素障害の企業別販売動向、市場シェア、市場集中度、競争動向 ・血色素障害の世界市場規模 ・血色素障害の北米市場分析（アメリカ、カナダ、メキシコ等） ・血色素障害のアメリカ市場規模推移 ・血色素障害のカナダ市場規模推移 ・血色素障害のメキシコ市場規模推移 ・血色素障害のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・血色素障害のドイツ市場規模推移 ・血色素障害のイギリス市場規模推移 ・血色素障害のロシア市場規模推移 ・血色素障害のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・血色素障害の日本市場規模推移 ・血色素障害の中国市場規模推移 ・血色素障害の韓国市場規模推移 ・血色素障害のインド市場規模推移 ・血色素障害の東南アジア市場規模推移 ・血色素障害の南米市場分析（ブラジル、アルゼンチン等） ・血色素障害の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・血色素障害の種類別分析/販売量、売上、市場シェア（サラセミア、鎌状赤血球症、その他のHb変異体疾患） ・血色素障害の用途別分析/市場規模（血液検査、遺伝子検査、着床前遺伝子診断（PGD）、その他） ・血色素障害の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・血色素障害の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Hemoglobinopathies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hemoglobinopathies.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Hemoglobinopathies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hemoglobinopathies market by product type and applications/end industries.
Market Segment by Companies, this report covers
Emmaus Life Sciences Inc.
Prolong Pharmaceuticals
Sangamo Therapeutics Inc.
Alnylam Pharmaceuticals
Gamida Cell
Sanofi
Bluebird Bio
Global Blood Therapeutics
Celgene Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Thalassemia
Sickle Cell Disease
Other Hb Variants Diseases
Market Segment by Applications, can be divided into
Blood Testing
Genetic Testing
Pre-Implantation Genetic Diagnosis (PGD)
Others
Table of Contents
1 Hemoglobinopathies Market Overview
1.1 Product Overview and Scope of Hemoglobinopathies
1.2 Classification of Hemoglobinopathies by Types
1.2.1 Global Hemoglobinopathies Revenue Comparison by Types (2019-2024)
1.2.2 Global Hemoglobinopathies Revenue Market Share by Types in 2018
1.2.3 Thalassemia
1.2.4 Sickle Cell Disease
1.2.5 Other Hb Variants Diseases
1.3 Global Hemoglobinopathies Market by Application
1.3.1 Global Hemoglobinopathies Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Blood Testing
1.3.3 Genetic Testing
1.3.4 Pre-Implantation Genetic Diagnosis (PGD)
1.3.5 Others
1.4 Global Hemoglobinopathies Market by Regions
1.4.1 Global Hemoglobinopathies Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Hemoglobinopathies Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hemoglobinopathies Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hemoglobinopathies Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Hemoglobinopathies Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hemoglobinopathies Status and Prospect (2014-2024)
1.5 Global Market Size of Hemoglobinopathies (2014-2024)
2 Company Profiles
2.1 Emmaus Life Sciences Inc.
2.1.1 Business Overview
2.1.2 Hemoglobinopathies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Emmaus Life Sciences Inc. Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
2.2 Prolong Pharmaceuticals
2.2.1 Business Overview
2.2.2 Hemoglobinopathies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Prolong Pharmaceuticals Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sangamo Therapeutics Inc.
2.3.1 Business Overview
2.3.2 Hemoglobinopathies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sangamo Therapeutics Inc. Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
2.4 Alnylam Pharmaceuticals
2.4.1 Business Overview
2.4.2 Hemoglobinopathies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Alnylam Pharmaceuticals Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
2.5 Gamida Cell
2.5.1 Business Overview
2.5.2 Hemoglobinopathies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Gamida Cell Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Hemoglobinopathies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
2.7 Bluebird Bio
2.7.1 Business Overview
2.7.2 Hemoglobinopathies Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bluebird Bio Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
2.8 Global Blood Therapeutics
2.8.1 Business Overview
2.8.2 Hemoglobinopathies Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Global Blood Therapeutics Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
2.9 Celgene Corporation
2.9.1 Business Overview
2.9.2 Hemoglobinopathies Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Celgene Corporation Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
3 Global Hemoglobinopathies Market Competition, by Players
3.1 Global Hemoglobinopathies Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Hemoglobinopathies Players Market Share
3.2.2 Top 10 Hemoglobinopathies Players Market Share
3.3 Market Competition Trend
4 Global Hemoglobinopathies Market Size by Regions
4.1 Global Hemoglobinopathies Revenue and Market Share by Regions
4.2 North America Hemoglobinopathies Revenue and Growth Rate (2014-2019)
4.3 Europe Hemoglobinopathies Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Hemoglobinopathies Revenue and Growth Rate (2014-2019)
4.5 South America Hemoglobinopathies Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Hemoglobinopathies Revenue and Growth Rate (2014-2019)
5 North America Hemoglobinopathies Revenue by Countries
5.1 North America Hemoglobinopathies Revenue by Countries (2014-2019)
5.2 USA Hemoglobinopathies Revenue and Growth Rate (2014-2019)
5.3 Canada Hemoglobinopathies Revenue and Growth Rate (2014-2019)
5.4 Mexico Hemoglobinopathies Revenue and Growth Rate (2014-2019)
6 Europe Hemoglobinopathies Revenue by Countries
6.1 Europe Hemoglobinopathies Revenue by Countries (2014-2019)
6.2 Germany Hemoglobinopathies Revenue and Growth Rate (2014-2019)
6.3 UK Hemoglobinopathies Revenue and Growth Rate (2014-2019)
6.4 France Hemoglobinopathies Revenue and Growth Rate (2014-2019)
6.5 Russia Hemoglobinopathies Revenue and Growth Rate (2014-2019)
6.6 Italy Hemoglobinopathies Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Hemoglobinopathies Revenue by Countries
7.1 Asia-Pacific Hemoglobinopathies Revenue by Countries (2014-2019)
7.2 China Hemoglobinopathies Revenue and Growth Rate (2014-2019)
7.3 Japan Hemoglobinopathies Revenue and Growth Rate (2014-2019)
7.4 Korea Hemoglobinopathies Revenue and Growth Rate (2014-2019)
7.5 India Hemoglobinopathies Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Hemoglobinopathies Revenue and Growth Rate (2014-2019)
8 South America Hemoglobinopathies Revenue by Countries
8.1 South America Hemoglobinopathies Revenue by Countries (2014-2019)
8.2 Brazil Hemoglobinopathies Revenue and Growth Rate (2014-2019)
8.3 Argentina Hemoglobinopathies Revenue and Growth Rate (2014-2019)
8.4 Colombia Hemoglobinopathies Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Hemoglobinopathies by Countries
9.1 Middle East and Africa Hemoglobinopathies Revenue by Countries (2014-2019)
9.2 Saudi Arabia Hemoglobinopathies Revenue and Growth Rate (2014-2019)
9.3 UAE Hemoglobinopathies Revenue and Growth Rate (2014-2019)
9.4 Egypt Hemoglobinopathies Revenue and Growth Rate (2014-2019)
9.5 Nigeria Hemoglobinopathies Revenue and Growth Rate (2014-2019)
9.6 South Africa Hemoglobinopathies Revenue and Growth Rate (2014-2019)
10 Global Hemoglobinopathies Market Segment by Type
10.1 Global Hemoglobinopathies Revenue and Market Share by Type (2014-2019)
10.2 Global Hemoglobinopathies Market Forecast by Type (2019-2024)
10.3 Thalassemia Revenue Growth Rate (2014-2024)
10.4 Sickle Cell Disease Revenue Growth Rate (2014-2024)
10.5 Other Hb Variants Diseases Revenue Growth Rate (2014-2024)
11 Global Hemoglobinopathies Market Segment by Application
11.1 Global Hemoglobinopathies Revenue Market Share by Application (2014-2019)
11.2 Hemoglobinopathies Market Forecast by Application (2019-2024)
11.3 Blood Testing Revenue Growth (2014-2019)
11.4 Genetic Testing Revenue Growth (2014-2019)
11.5 Pre-Implantation Genetic Diagnosis (PGD) Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Hemoglobinopathies Market Size Forecast (2019-2024)
12.1 Global Hemoglobinopathies Market Size Forecast (2019-2024)
12.2 Global Hemoglobinopathies Market Forecast by Regions (2019-2024)
12.3 North America Hemoglobinopathies Revenue Market Forecast (2019-2024)
12.4 Europe Hemoglobinopathies Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Hemoglobinopathies Revenue Market Forecast (2019-2024)
12.6 South America Hemoglobinopathies Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Hemoglobinopathies Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Hemoglobinopathies Picture
Table Product Specifications of Hemoglobinopathies
Table Global Hemoglobinopathies and Revenue (Million USD) Market Split by Product Type
Figure Global Hemoglobinopathies Revenue Market Share by Types in 2018
Figure Thalassemia Picture
Figure Sickle Cell Disease Picture
Figure Other Hb Variants Diseases Picture
Table Global Hemoglobinopathies Revenue (Million USD) by Application (2014-2024)
Figure Hemoglobinopathies Revenue Market Share by Applications in 2018
Figure Blood Testing Picture
Figure Genetic Testing Picture
Figure Pre-Implantation Genetic Diagnosis (PGD) Picture
Figure Others Picture
Table Global Market Hemoglobinopathies Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Hemoglobinopathies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Hemoglobinopathies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Hemoglobinopathies Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Hemoglobinopathies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Hemoglobinopathies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Hemoglobinopathies Revenue (Million USD) and Growth Rate (2014-2024)
Table Emmaus Life Sciences Inc. Basic Information, Manufacturing Base and Competitors
Table Emmaus Life Sciences Inc. Hemoglobinopathies Type and Applications
Table Emmaus Life Sciences Inc. Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
Table Prolong Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Prolong Pharmaceuticals Hemoglobinopathies Type and Applications
Table Prolong Pharmaceuticals Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
Table Sangamo Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table Sangamo Therapeutics Inc. Hemoglobinopathies Type and Applications
Table Sangamo Therapeutics Inc. Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alnylam Pharmaceuticals Hemoglobinopathies Type and Applications
Table Alnylam Pharmaceuticals Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
Table Gamida Cell Basic Information, Manufacturing Base and Competitors
Table Gamida Cell Hemoglobinopathies Type and Applications
Table Gamida Cell Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Hemoglobinopathies Type and Applications
Table Sanofi Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
Table Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table Bluebird Bio Hemoglobinopathies Type and Applications
Table Bluebird Bio Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
Table Global Blood Therapeutics Basic Information, Manufacturing Base and Competitors
Table Global Blood Therapeutics Hemoglobinopathies Type and Applications
Table Global Blood Therapeutics Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table Celgene Corporation Hemoglobinopathies Type and Applications
Table Celgene Corporation Hemoglobinopathies Revenue, Gross Margin and Market Share (2017-2018)
Table Global Hemoglobinopathies Revenue (Million USD) by Players (2014-2019)
Table Global Hemoglobinopathies Revenue Share by Players (2014-2019)
Figure Global Hemoglobinopathies Revenue Share by Players in 2017
Figure Global Hemoglobinopathies Revenue Share by Players in 2018
Figure Global Top 5 Players Hemoglobinopathies Revenue Market Share in 2018
Figure Global Top 10 Players Hemoglobinopathies Revenue Market Share in 2018
Figure Global Hemoglobinopathies Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Hemoglobinopathies Revenue (Million USD) by Regions (2014-2019)
Table Global Hemoglobinopathies Revenue Market Share by Regions (2014-2019)
Figure Global Hemoglobinopathies Revenue Market Share by Regions (2014-2019)
Figure Global Hemoglobinopathies Revenue Market Share by Regions in 2018
Figure North America Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Europe Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure South America Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Table North America Hemoglobinopathies Revenue by Countries (2014-2019)
Table North America Hemoglobinopathies Revenue Market Share by Countries (2014-2019)
Figure North America Hemoglobinopathies Revenue Market Share by Countries (2014-2019)
Figure North America Hemoglobinopathies Revenue Market Share by Countries in 2018
Figure USA Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Canada Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Mexico Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Table Europe Hemoglobinopathies Revenue (Million USD) by Countries (2014-2019)
Figure Europe Hemoglobinopathies Revenue Market Share by Countries (2014-2019)
Figure Europe Hemoglobinopathies Revenue Market Share by Countries in 2018
Figure Germany Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure UK Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure France Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Russia Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Italy Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Hemoglobinopathies Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Hemoglobinopathies Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Hemoglobinopathies Revenue Market Share by Countries in 2018
Figure China Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Japan Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Korea Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure India Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Table South America Hemoglobinopathies Revenue by Countries (2014-2019)
Table South America Hemoglobinopathies Revenue Market Share by Countries (2014-2019)
Figure South America Hemoglobinopathies Revenue Market Share by Countries (2014-2019)
Figure South America Hemoglobinopathies Revenue Market Share by Countries in 2018
Figure Brazil Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Argentina Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Colombia Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Hemoglobinopathies Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Hemoglobinopathies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hemoglobinopathies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hemoglobinopathies Revenue Market Share by Countries in 2018
Figure Saudi Arabia Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure UAE Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Egypt Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure Nigeria Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Figure South Africa Hemoglobinopathies Revenue and Growth Rate (2014-2019)
Table Global Hemoglobinopathies Revenue (Million USD) by Type (2014-2019)
Table Global Hemoglobinopathies Revenue Share by Type (2014-2019)
Figure Global Hemoglobinopathies Revenue Share by Type (2014-2019)
Figure Global Hemoglobinopathies Revenue Share by Type in 2018
Table Global Hemoglobinopathies Revenue Forecast by Type (2019-2024)
Figure Global Hemoglobinopathies Market Share Forecast by Type (2019-2024)
Figure Global Thalassemia Revenue Growth Rate (2014-2019)
Figure Global Sickle Cell Disease Revenue Growth Rate (2014-2019)
Figure Global Other Hb Variants Diseases Revenue Growth Rate (2014-2019)
Table Global Hemoglobinopathies Revenue by Application (2014-2019)
Table Global Hemoglobinopathies Revenue Share by Application (2014-2019)
Figure Global Hemoglobinopathies Revenue Share by Application (2014-2019)
Figure Global Hemoglobinopathies Revenue Share by Application in 2018
Table Global Hemoglobinopathies Revenue Forecast by Application (2019-2024)
Figure Global Hemoglobinopathies Market Share Forecast by Application (2019-2024)
Figure Global Blood Testing Revenue Growth Rate (2014-2019)
Figure Global Genetic Testing Revenue Growth Rate (2014-2019)
Figure Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Hemoglobinopathies Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Hemoglobinopathies Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Hemoglobinopathies Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Hemoglobinopathies Revenue Market Forecast (2019-2024)
Figure Europe Hemoglobinopathies Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Hemoglobinopathies Revenue Market Forecast (2019-2024)
Figure South America Hemoglobinopathies Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Hemoglobinopathies Revenue Market Forecast (2019-2024)
世界の鎌状赤血球症診断市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Sickle Cell Disease Diagnosis market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Ch…- 鎌状赤血球症治療市場：世界及び中国市場分析・予測（～2024年） Sickle Cell Disease Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Sickle Cell Disease Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Sickle Cel…
- 貧血治療薬の世界市場… Scope of the Report: The global Anemia Treatment Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, al…
- 世界の細胞療法プロセッシング市場予測（～2024年）：企業別、地域別、種類・用途別 Cell therapy is the transplantation of human cells to replace or repair damaged tissue or cells. With new technologies and innovative products, many different types of cells can be used as part of a therapy or a treatment for a variety of diseases and conditions. Scope of the Report: The global Cell…
- 世界の筋骨格障害幹細胞療法市場予測（～2024年） Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder Stem Cell Therapy. Scope of the Report: The global Musculoskeletal Disorder Stem Cell Therapy market is valued at xx million USD in 2018 and is expected to reach…